First Time Loading...
S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 4.95 USD -2.17% Market Closed
Updated: Apr 26, 2024
Section:
 

Intrinsic Value

SOPH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. [ Read More ]

The intrinsic value of one SOPH stock under the Base Case scenario is 5.93 USD. Compared to the current market price of 4.95 USD, Sophia Genetics SA is Undervalued by 17%.

Key Points:
SOPH Intrinsic Value
Base Case
5.93 USD
Undervaluation 17%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case
What is intrinsic value?

Valuation Backtest
Sophia Genetics SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling SOPH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Sophia Genetics SA

What unique competitive advantages
does Sophia Genetics SA hold over its rivals?

What risks and challenges
does Sophia Genetics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Sophia Genetics SA.

Provide an overview of the primary business activities
of Sophia Genetics SA.

What unique competitive advantages
does Sophia Genetics SA hold over its rivals?

What risks and challenges
does Sophia Genetics SA face in the near future?

Summarize the latest earnings call
of Sophia Genetics SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sophia Genetics SA.

Provide P/S
for Sophia Genetics SA.

Provide P/E
for Sophia Genetics SA.

Provide P/OCF
for Sophia Genetics SA.

Provide P/FCFE
for Sophia Genetics SA.

Provide P/B
for Sophia Genetics SA.

Provide EV/S
for Sophia Genetics SA.

Provide EV/GP
for Sophia Genetics SA.

Provide EV/EBITDA
for Sophia Genetics SA.

Provide EV/EBIT
for Sophia Genetics SA.

Provide EV/OCF
for Sophia Genetics SA.

Provide EV/FCFF
for Sophia Genetics SA.

Provide EV/IC
for Sophia Genetics SA.

Show me price targets
for Sophia Genetics SA made by professional analysts.

What are the Revenue projections
for Sophia Genetics SA?

How accurate were the past Revenue estimates
for Sophia Genetics SA?

What are the Net Income projections
for Sophia Genetics SA?

How accurate were the past Net Income estimates
for Sophia Genetics SA?

What are the EPS projections
for Sophia Genetics SA?

How accurate were the past EPS estimates
for Sophia Genetics SA?

What are the EBIT projections
for Sophia Genetics SA?

How accurate were the past EBIT estimates
for Sophia Genetics SA?

Compare the revenue forecasts
for Sophia Genetics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sophia Genetics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sophia Genetics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sophia Genetics SA compared to its peers.

Compare the P/E ratios
of Sophia Genetics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Sophia Genetics SA with its peers.

Analyze the financial leverage
of Sophia Genetics SA compared to its main competitors.

Show all profitability ratios
for Sophia Genetics SA.

Provide ROE
for Sophia Genetics SA.

Provide ROA
for Sophia Genetics SA.

Provide ROIC
for Sophia Genetics SA.

Provide ROCE
for Sophia Genetics SA.

Provide Gross Margin
for Sophia Genetics SA.

Provide Operating Margin
for Sophia Genetics SA.

Provide Net Margin
for Sophia Genetics SA.

Provide FCF Margin
for Sophia Genetics SA.

Show all solvency ratios
for Sophia Genetics SA.

Provide D/E Ratio
for Sophia Genetics SA.

Provide D/A Ratio
for Sophia Genetics SA.

Provide Interest Coverage Ratio
for Sophia Genetics SA.

Provide Altman Z-Score Ratio
for Sophia Genetics SA.

Provide Quick Ratio
for Sophia Genetics SA.

Provide Current Ratio
for Sophia Genetics SA.

Provide Cash Ratio
for Sophia Genetics SA.

What is the historical Revenue growth
over the last 5 years for Sophia Genetics SA?

What is the historical Net Income growth
over the last 5 years for Sophia Genetics SA?

What is the current Free Cash Flow
of Sophia Genetics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sophia Genetics SA.

Popular Strategic Analysis Valuation Future Outlook Peer Analysis Profitability Solvency Financials
Financials
Revenue
Operating Income
Net Income
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Balance Sheet Decomposition
Sophia Genetics SA

206.2m
Assets
54.7m
Liabilities
206.2m
Assets
54.7m
Liabilities
Current Assets 148m
Cash & Short-Term Investments 123.3m
Receivables 13.6m
Other Current Assets 11.2m
Non-Current Assets 58.1m
PP&E 23.1m
Intangibles 27.2m
Other Non-Current Assets 7.8m
Current Liabilities 35.6m
Accounts Payable 5.4m
Accrued Liabilities 17.8m
Other Current Liabilities 12.4m
Non-Current Liabilities 19.1m
Long-Term Debt 15.7m
Other Non-Current Liabilities 3.4m
Efficiency

Earnings Waterfall
Sophia Genetics SA

Revenue
62.4m USD
Cost of Revenue
-19.5m USD
Gross Profit
42.9m USD
Operating Expenses
-117.7m USD
Operating Income
-74.8m USD
Other Expenses
-4.2m USD
Net Income
-79m USD
Gross Margin
Operating Margin
Net Margin
FCF Margin
ROE
ROA
ROIC
ROCE

Free Cash Flow Analysis
Sophia Genetics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

SOPH Profitability Score
Profitability Due Diligence

Sophia Genetics SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
Exceptional Revenue Growth Forecast
31/100
Profitability
Score

Sophia Genetics SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

SOPH Solvency Score
Solvency Due Diligence

Sophia Genetics SA's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
55/100
Solvency
Score

Sophia Genetics SA's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SOPH Price Targets Summary
Sophia Genetics SA

Wall Street analysts forecast SOPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOPH is 8.84 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

SOPH Lowest Forecast
Wall Street Target
8.08 USD
63% Upside
SOPH Average Forecast
Wall Street Target
8.84 USD
79% Upside
SOPH Highest Forecast
Wall Street Target
10.5 USD
112% Upside
Lowest
Price Target
8.08 USD
63% Upside
Average
Price Target
8.84 USD
79% Upside
Highest
Price Target
10.5 USD
112% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

SOPH Price
Sophia Genetics SA

1M 1M
+1%
6M 6M
+24%
1Y 1Y
+6%
3Y 3Y
-73%
5Y 5Y
-73%
10Y 10Y
-73%
Annual Price Range
4.95
52w Low
2.3
52w High
5.62
Price Metrics
Average Annual Return -51.74%
Standard Deviation of Annual Returns 46.46%
Max Drawdown -91%
Shares Statistics
Market Capitalization 322.9m USD
Shares Outstanding 65 301 400
Percentage of Shares Shorted 0.11%

SOPH Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sophia Genetics SA

Country

Switzerland

Industry

Health Care

Market Cap

322.9m USD

Dividend Yield

0%

Description

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

Contact

VAUD
Rue du Centre 172, Saint Sulpice
+41216941060.0
https://www.sophiagenetics.com/

IPO

2021-07-23

Employees

518

Officers

Co-Founder, CEO & Director
Dr. Jurgi Camblong M.B.A., Ph.D.
Executive VP, CFO & COO
Mr. Ross Jordan Muken B.Sc.
Senior VP & CTO
Mr. Abhimanyu Verma
Executive VP & Chief Scientific Officer
Dr. Zhenyu Xu Ph.D.
Vice President of Investor Relations
Katherine Bailon
Executive VP, Chief Legal & Compliance Officer
Mr. Daan van Well L.L.M., M.B.A.
Show More
Senior VP & Chief People Officer
Ms. Manuela Da Silva Valente B.A.
VP & MD of EMEA
Mr. Kevin Puylaert
Executive VP, Chief Medical Officer & Chief Product Officer
Dr. Philippe Menu M.B.A., M.D., Ph.D.
Senior VP & Chief BioPharma Officer
Mr. Peter Casasanto
Show Less

See Also

Summary
SOPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
SOPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SOPH stock valuation using valuation multiples.
Wall Street Estimates
SOPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SOPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is the Intrinsic Value of one SOPH stock?

The intrinsic value of one SOPH stock under the Base Case scenario is 5.93 USD.

Is SOPH stock undervalued or overvalued?

Compared to the current market price of 4.95 USD, Sophia Genetics SA is Undervalued by 17%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.